NDC 27505-004

Apokyn 30 mg per 3 mL injection

On the label: MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc..

United Kingdom: 2Germany: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Kennet Bioservices LtdSwindon, United KingdomMakes it and tests it Problems found, fixed voluntarilyAug 18, 2022 · 2 inspections
Macfarlan Smith LimitedEdinburgh, United KingdomMakes the active ingredient Problems found, fixed voluntarilyNov 29, 2021 · 4 inspections
Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse)Ravensburg, GermanyMakes it and tests it Problems found, fixed voluntarilyJul 13, 2022 · 10 inspections
A+ Secure Packaging, LLCLa Vergne, TN, United StatesPackages it and labels it No problems foundJun 7, 2023 · 4 inspections
Labcorp Early Development Laboratories LimitedHarrogate, United KingdomTests it Problems found, fixed voluntarilyMar 9, 2022 · 8 inspections
Wickham Micro LimitedGosport, United KingdomTests it Problems found, fixed voluntarilyFeb 2, 2023 · 5 inspections

Product details

Generic drug
Apomorphine: every company that makes it
Form
injection, subcutaneous
Strength
30 mg per 3 mL
Approval
NDA NDA021264
On the market since
Jul 2, 2004
Package NDCs
27505-004-01 27505-004-05
Official label
DailyMed (National Library of Medicine), updated Oct 10, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?